PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 97 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,067 | +80.1% | 137,809 | 0.0% | 0.00% | – |
| Q2 2023 | $22,807 | -81.2% | 137,809 | +11.0% | 0.00% | – |
| Q1 2023 | $121,130 | +8.1% | 124,109 | +15.2% | 0.00% | – |
| Q4 2022 | $112,026 | -9.7% | 107,717 | 0.0% | 0.00% | – |
| Q3 2022 | $124,000 | -38.3% | 107,717 | 0.0% | 0.00% | – |
| Q2 2022 | $201,000 | -40.7% | 107,717 | -3.7% | 0.00% | – |
| Q1 2022 | $339,000 | -19.7% | 111,853 | +0.1% | 0.00% | – |
| Q4 2021 | $422,000 | -28.4% | 111,689 | -1.9% | 0.00% | – |
| Q3 2021 | $589,000 | +27.2% | 113,878 | -5.8% | 0.00% | – |
| Q2 2021 | $463,000 | -67.9% | 120,846 | -78.4% | 0.00% | – |
| Q1 2021 | $1,441,000 | -0.7% | 560,674 | -3.4% | 0.00% | – |
| Q4 2020 | $1,451,000 | +24.7% | 580,546 | +3.2% | 0.00% | – |
| Q3 2020 | $1,164,000 | -35.4% | 562,696 | -3.1% | 0.00% | – |
| Q2 2020 | $1,801,000 | +44.7% | 580,853 | +6.3% | 0.00% | – |
| Q1 2020 | $1,245,000 | -35.4% | 546,240 | +2.6% | 0.00% | – |
| Q4 2019 | $1,927,000 | +5.8% | 532,159 | -0.4% | 0.00% | – |
| Q3 2019 | $1,821,000 | -18.0% | 534,213 | +13.0% | 0.00% | -100.0% |
| Q2 2019 | $2,221,000 | +37.3% | 472,617 | -2.1% | 0.00% | – |
| Q1 2019 | $1,618,000 | +31.8% | 482,943 | +4.6% | 0.00% | – |
| Q4 2018 | $1,228,000 | -55.0% | 461,925 | -5.1% | 0.00% | -100.0% |
| Q3 2018 | $2,726,000 | +52.4% | 486,690 | +37.9% | 0.00% | – |
| Q2 2018 | $1,789,000 | -26.1% | 352,939 | -0.6% | 0.00% | -100.0% |
| Q1 2018 | $2,422,000 | +0.8% | 355,208 | +11.6% | 0.00% | 0.0% |
| Q4 2017 | $2,403,000 | +30.0% | 318,294 | -0.9% | 0.00% | – |
| Q3 2017 | $1,849,000 | +13.8% | 321,134 | +0.0% | 0.00% | – |
| Q2 2017 | $1,625,000 | +3432.6% | 321,118 | +1184.5% | 0.00% | – |
| Q3 2016 | $46,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |